"The Big Pharma returns are more impressive than they appear on charts when you include the compounded (reinvested) dividends."
Really? I doubt that the comparison to GILD would change much. Of course, why should they be compared to GILD? Why not REGN? Just as inappropriate. Much more appropriate would be SPY. The point is whether the section outperformed the market. It clearly did, which I think is your point.
Market Data 
Markets 
AI
